![Kimi Iguchi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kimi Iguchi
Direktor/Vorstandsmitglied bei
Disarm Therapeutics, Inc.
Profil
Derzeit bekleidet Kimi E. Iguchi die Position des Chief Financial Officer & Treasurer bei SAGE Therapeutics, Inc. Frau Iguchi ist außerdem Mitglied des Vorstands von Disarm Therapeutics, Inc. Zuvor war sie Vice President-Finance bei Cyberkinetics Neurotechnology Systems, Inc., Chief Operating Officer-North America Region bei Santhera Pharmaceuticals Holding AG, Senior Manager-External Reporting bei Biogen, Inc. und Finance Manager bei Biogen MA, Inc. (eine Tochtergesellschaft von Biogen, Inc.), Senior Director-Finance, Reporting & Analysis bei Millennium Pharmaceuticals, Inc. und Manager-Business Assurance bei PricewaterhouseCoopers LLP. Frau Iguchi hat einen Undergraduate-Abschluss der Drew University und einen MBA der Northeastern University.
Aktive Positionen von Kimi Iguchi
| Unternehmen | Position | Beginn |
|---|---|---|
Disarm Therapeutics, Inc.
 Disarm Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat patients with neurological diseases | Direktor/Vorstandsmitglied | 25.10.2018 |
Ehemalige bekannte Positionen von Kimi Iguchi
| Unternehmen | Position | Ende |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Finanzdirektor/CFO | 31.10.2024 |
| SANTHERA PHARMACEUTICALS HOLDING AG | Corporate Officer/Principal | 01.09.2011 |
Cyberkinetics Neurotechnology Systems, Inc.
 Cyberkinetics Neurotechnology Systems, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices | Finanzdirektor/CFO | 31.05.2007 |
| BIOGEN INC. | Corporate Officer/Principal | 01.01.1998 |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Corporate Officer/Principal | 01.01.1995 |
Ausbildung von Kimi Iguchi
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
75
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Develops and manufactures drugs related to immunology, neurobiology and oncology | Health Technology |
Drew University
 Drew University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
Santhera Pharmaceuticals Holding AG
 Santhera Pharmaceuticals Holding AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of neuromuscular diseases | Health Technology |
Cyberkinetics Neurotechnology Systems, Inc.
Cyberkinetics Neurotechnology Systems, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
Disarm Therapeutics, Inc.
Disarm Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat patients with neurological diseases | Health Technology |
